Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adalimumab in Moderately to Severely Active Psoriatic Arthritis
NCT00646386Phase 2Completed
- Sponsor
- Abbott Laboratories
- Start
- Mar 2003
- Primary completion
- Apr 2004
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 2 trial of adalimumab in psoriatic arthritis (PsA), sponsored by Abbott Laboratories. Started Mar 2003; status: completed.
02
Drugs
03
Conditions
psoriatic arthritis (PsA)
Beyond the preview
Go deeper on NCT00646386.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00646386.